<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">SANP</journal-id>
      <journal-title-group>
        <journal-title>Swiss Archives of Neurology, Psychiatry and Psychotherapy</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2297-7007</issn>
      <issn pub-type="ppub">2297-6981</issn>
      <publisher>
        <publisher-name>EMH Schweizerischer Ärzteverlag AG</publisher-name>
        <publisher-loc>Farnsburgerstrasse 8
CH-4132 Muttenz</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">03035</article-id>
      <article-id pub-id-type="doi">10.4414/sanp.2019.03035</article-id>
      <article-categories>
        <!-- rubric -->
        <subj-group subj-group-type="Article Type">
          <subject>Original article</subject>
        </subj-group>
        <!-- topics -->
        <subj-group subj-group-type="Classification">
          <subject>Infectious disorders of the nervous system</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Pronostic évolutif de la crypto­coccose neuroméningée au Togo
</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-1" contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Agba</surname>
            <given-names>Léhleng</given-names>
          </name>
          <email>thierrielle@gmail.com</email>
          <aff>Kara University Teaching hospital | Neurology | Kara | KARA | Po BOX 18 Kara | TOGO | 00228 90 25 63 31</aff>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Guinhouya</surname>
            <given-names>Kokou M.</given-names>
          </name>
          <email/>
          <aff/>
        </contrib>
        <contrib id="author-3" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Kumako</surname>
            <given-names>Vincent</given-names>
          </name>
          <email/>
          <aff>Kara University Teaching hospital</aff>
        </contrib>
        <contrib id="author-4" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Anayo</surname>
            <given-names>Komla N.</given-names>
          </name>
          <email/>
          <aff>Centre hospitalier Sylvanus Olympio</aff>
        </contrib>
        <contrib id="author-5" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname>Belo</surname>
            <given-names>Mofou</given-names>
          </name>
          <email/>
          <aff/>
        </contrib>
        <contrib id="author-6" contrib-type="author" corresp="no">
          <contrib-id contrib-id-type="orcid"/>
          <name>
            <surname> Balogou</surname>
            <given-names>Agnon A. K.</given-names>
          </name>
          <email/>
          <aff/>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2019.06.17">
        <day>17</day>
        <month>06</month>
        <year>2019</year>
      </pub-date>
      <volume>170</volume>
      <issue>03</issue>
      <fpage>0</fpage>
      <lpage>0</lpage>
      <permissions>
        <copyright-statement>Copyright: EMH Schweizerischer Ärzteverlag AG</copyright-statement>
        <copyright-year>2019</copyright-year>
        <copyright-holder>EMH Schweizerischer Ärzteverlag AG</copyright-holder>
        <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
          <license-p>"Swiss Archives of Neurology, Psychiatry and Psychotherapy" is an open access publication of EMH published in accordance with the terms of the Creative Commons licence attribution - NonCommercial - NoDerivatives 4.0 International. You are free to share, copy and redistribute the material in any medium or format under the following terms:</license-p>
          <license-p>Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.</license-p>
          <license-p>NonCommercial — You may not use the material for commercial purposes.</license-p>
          <license-p>NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.</license-p>
          <license-p>"Non-commercial" means not primarily intended for or directed towards commercial advantage or monetary compensation. The incorporation of publications in commercial products, the use of publications to advertise for commercial products or services and any other usage that directly or indirectly pursues commercial interests is subject to the express previous consent of the publishing house as part of a written agreement.</license-p>
          <license-p>Please send us your request in writing. Exact indication of the publication from which you would like to reproduce material and detailed information about its intended use help to facilitate and expedite request processing.</license-p>
        </license>
      </permissions>
      <abstract abstract-type="article" xml:lang="en">&lt;p&gt;Introduction: Neuromeningeal cryptococcosis (NMC) is the most common mycotic meningitis infection occurring during HIV / AIDS. It is the leading cause of clear-fluid meningitis in patients with human immunodeficiency virus (HIV). Its evolutionary prognosis remains in the majority of unfavorable for several reasons.

Objective: To describe the epidemiological and clinical aspects of the NMC and its evolutionary profile in adults in the medical departments of the Sylvanus Olympio Teaching Hospital of Lomé

Patients and methods: This was a retrospective study from January 1, 2007 to December 31, 2016 conducted from hospital records in the medical and medical specialty services of the Sylvanus Olympio University Hospital in Lomé, Togo.

Results: The hospital prevalence of the NMC was 1.2% with a male predominance (H/F=1.3). The average age of the patients was 34.58 years old, with a high representation of the 30-39 and 20-29 age groups. Civil servants (23.91%), students (15.21%), traders (15.21%) were the most affected. The main reasons for admission were fever (73.9%), headache (69.5%), seizures (56.5%) and vomiting (45.6%). The main physical signs were general impairment syndrome (95.6%), infectious syndrome (91.3%) meningeal syndrome (84.7%) and confusional syndrome (58.6%). All our patients were HIV-positive1 and 97.72% had a CD4 count of less than 100. The CSF examination allowed the diagnosis to be made by direct examination with Chinese ink in 93.47% of patients or to culture in the case of negativity on direct examination (6.53%). The treatment was made of Amphotericin B and Flucitosin in 17.39% of cases and Fluconazole in 82.60% of cases. Treatment progress was marked by death in all our patients occurring after an average of 17.34 days of hospitalization.

Conclusion: Because of its high mortality rate, NMC is a diagnosis to be considered in principle in HIV-positive patients with headache, fever or confusional syndrome.&lt;/p&gt;</abstract>
    </article-meta>
  </front>
  <body/>
  <back/>
</article>
